Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scopus BioPharma (SCPS)
OTHER OTC:SCPS
Holding SCPS?
Track your performance easily
SCPS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.06
Previous Close$0.04
Volume450.00
Average Volume (3M)N/A
Market Cap
$12.63K
Enterprise Value-$1.40M
Total Cash (Recent Filing)$362.10K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-15.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,084,264
10 Day Avg. Volume52,918
30 Day Avg. VolumeN/A
Standard Deviation44.11
R-Squared0.00166
Alpha5.94
Financial Highlights & Ratios
Price to Book (P/B)-0.00100
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SCPS FAQ
What was Scopus BioPharma’s price range in the past 12 months?
Scopus BioPharma lowest stock price was $0.03 and its highest was $0.06 in the past 12 months.
What is Scopus BioPharma’s market cap?
Currently, no data Available
When is Scopus BioPharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scopus BioPharma’s earnings last quarter?
Currently, no data Available
Is Scopus BioPharma overvalued?
According to Wall Street analysts Scopus BioPharma’s price is currently Overvalued.
Does Scopus BioPharma pay dividends?
Scopus BioPharma does not currently pay dividends.
What is Scopus BioPharma’s EPS estimate?
Scopus BioPharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scopus BioPharma have?
Scopus BioPharma has 42,084,263 shares outstanding.
What happened to Scopus BioPharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scopus BioPharma?
Currently, no hedge funds are holding shares in SCPS
---
Company Description
Scopus BioPharma
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. The company product candidates would utilize synthetically-produced cannabinoids as opposed to plant-derived compounds.
---
Adial Pharmaceuticals
―
Cyclacel Pharmaceuticals
―
TRACON Pharmaceuticals
―
180 Life Sciences
―
---